Safety of bronchoscopy in patients with malignant hematologic disorders
Open Access
- 11 September 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Pulmonary Medicine
- Vol. 20 (1), 1-6
- https://doi.org/10.1186/s12890-020-01283-8
Abstract
Factors affecting the safety of bronchoscopy in patients with malignant hematologic disorders have not been well described. We evaluated the safety of bronchoscopy and describe factors affecting its complication rate in such patients. Between January 2009 and December 2018, 316 bronchoscopies in 282 patients with malignant hematologic disorders and pulmonary infiltrates were performed at our institution. The bronchoscopic procedure used and its complications were evaluated. The most common underlying disease was acute myeloid leukemia (134/282 patients, 47.5%). Platelet transfusion was performed the day before or the day of bronchoscopy in 42.4%, supplemental oxygen was administered before the procedure in 23.1%, and midazolam was used in 74.4%. Thirty-five bronchoscopies (11.1%) were complicated by hemoptysis and 7 patients developed pneumothorax, 4 of whom required thoracic drainage. Two patients (0.6%) were intubated within 48 h of the procedure and prolonged oxygen desaturation (> 48 h) occurred in 3.8%. Multivariate analysis showed that only use of midazolam significantly reduced the risk of prolonged oxygen desaturation (hazard ratio 0.28, 95% confidence interval 0.09–0.85, p = 0.03). Transbronchial lung biopsy significantly increased the risk of hemoptysis (hazard ratio 10.40, 95% confidence interval 4.18–25.90, p = 0.00), while use of midazolam significantly reduced the risk (hazard ratio 0.31, 95% confidence interval 0.14–0.73, p = 0.01). Bronchoscopy is relatively safe in patients with malignant hematologic disorders. Caution and judicious use of sedatives may improve the patient’s procedural tolerance and lower complications.Keywords
Other Versions
Funding Information
- Okinaka Memorial Institute for Medical Research (Hironori Uruga)
This publication has 13 references indexed in Scilit:
- Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium—A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique StudyJournal of Clinical Oncology, 2013
- Midazolam in Flexible Bronchoscopy PremedicationJournal of Bronchology & Interventional Pulmonology, 2013
- Diagnostic Bronchoscopy in Solid-Organ and Hematopoietic Stem Cell TransplantationAnnals of the American Thoracic Society, 2013
- Sedação com midazolam na broncofibroscopia – estudo prospetivoRevista Portuguesa de Pneumologia, 2012
- The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantationBlood, 2008
- The Influence of Diagnostic Bronchoscopy on Clinical Outcomes Comparing Adult Autologous and Allogeneic Bone Marrow Transplant Patients*Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2005
- COMPARISON OF MIDAZOLAM WITH PROPOFOL FOR SEDATION IN OUTPATIENT BRONCHOSCOPYBritish Journal of Anaesthesia, 1993
- The role of fiberoptic bronchoscopy in the evaluation of immunocompromised hosts with diffuse pulmonary infiltrates.Published by Elsevier BV ,1985
- Fiberoptic bronchoscopy in the immunocompromised host: the significance of a "nonspecific" transbronchial biopsy.Published by Elsevier BV ,1980
- Fibreoptic bronchoscopy and diagnosis of pulmonary lesions in lymphoma and leukaemia.Thorax, 1980